3-methyl-6,7,8,9-tetrahydro-5H-imidazo[1,5-a]azepine | 1394843-63-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吖庚因类
• 英文名称: 3-methyl-6,7,8,9-tetrahydro-5H-imidazo[1,5-a]azepine
• CAS: 1394843-63-0
• 化学式: C₉H₁₄N₂
• 分子量: 150.224
• InChiKey: JZHDNKXTPOBZEZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  7-azidohept-1-yne 、 乙腈 在 gold(III) chloride 、 甲烷磺酸 作用下， 反应 10.0h， 以20%的产率得到3-methyl-6,7,8,9-tetrahydro-5H-imidazo[1,5-a]azepine
  参考文献：
  名称：

  Synthesis of Bicyclic Imidazoles via [2 + 3] Cycloaddition between Nitriles and Regioselectively Generated α-Imino Gold Carbene Intermediates

  摘要：

  The cyclic alpha-imino gold carbene intermediate B is most likely generated in situ via regioselective nitrene transfer from an azido group to a tethered terminal alkyne in the presence of a gold catalyst and at ambient temperature. This highly electrophilic intermediate can react with a weakly nucleophilic nitrile, which is used as the reaction solvent, to deliver a bicyclic imidazole rapidly in an overall bimolecular [2 + 2 + 1] cycloaddition and in mostly serviceable yield. The competing intramolecular Huisgen reaction, although likely also catalyzed by gold, is minimized by using AuCl3 as the catalyst.

  DOI：

  10.1021/ol302102h

文献信息

• Multi-cyclic cinnamide derivatives
  申请人：Kimura Teiji

  公开号：US20070219181A1

  公开（公告）日：2007-09-20

  The present invention provides a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar 1 represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, Ar 2 represents a phenyl group that may be substituted with a C1-6 alkoxy group, or the like, X 1 represents a double bond or the like, and Het represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, which is effective as a therapeutic or prophylactic agent for a disease caused by Aβ.

  本发明提供了一种由以下公式（I）表示的化合物或其药理学上可接受的盐，其中Ar1代表可能用C1-6烷基等取代的咪唑基团，Ar2代表可能用C1-6烷氧基等取代的苯基团，X1代表双键等，Het代表可能用C1-6烷基等取代的咪唑基团，该化合物对由Aβ引起的疾病具有治疗或预防作用。
• MULTI-CYCLIC CINNAMIDE DERIVATIVES
  申请人：KIMURA Teiji

  公开号：US20100168095A1

  公开（公告）日：2010-07-01

  The present invention provides a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar1 represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, Ar2 represents a phenyl group that may be substituted with a C1-6 alkoxy group, or the like, X1 represents a double bond or the like, and Het represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, which is effective as a therapeutic or prophylactic agent for a disease caused by Aβ.

  本发明提供了一种化合物，其化学式表示为(I)：或其药学上可接受的盐，其中Ar1代表可被C1-6烷基等取代的咪唑基团，Ar2代表可被C1-6烷氧基等取代的苯基团，X1代表双键等，Het代表可被C1-6烷基等取代的咪唑基团，该化合物对由Aβ引起的疾病具有治疗或预防作用。
• TYPE III SECRETION INHIBITORS, ANALOGS AND USES THEREOF
  申请人：University of Massachusetts

  公开号：US20140323483A1

  公开（公告）日：2014-10-30

  The invention, in some aspects, relates to compounds and compositions useful for inhibiting Type III secretion systems in pathogenic bacteria, such as Yersinia Pestis . In some aspects, the invention relates to methods for discovering inhibitors of the Type III secretion system and uses of such inhibitors in the treatment and prevention of disease.

  该发明在某些方面与化合物和组合物有关，这些化合物和组合物可用于抑制病原细菌（如鼠疫耶尔森氏菌）中的第三型分泌系统。在某些方面，该发明涉及发现第三型分泌系统抑制剂的方法以及这些抑制剂在疾病的治疗和预防中的应用。
• EP1992618A1
  申请人：——

  公开号：EP1992618A1

  公开（公告）日：2008-11-19
• US7713993B2
  申请人：——

  公开号：US7713993B2

  公开（公告）日：2010-05-11